Loading...
PKX is not a good buy right now for an impatient trader. Despite a bullish moving-average stack, the near-term setup is weakened by contracting momentum, bearish options flow (heavy put volume), a negative statistical forward-trend read, and fundamentally deteriorating earnings. I would avoid new buys here and prefer to be out/trim ahead of the next earnings catalyst unless price can regain the ~64.6 resistance zone decisively.
Trend/price context (pre-market): Trading around 60 pre-market (-2.80%), sitting just below the pivot (60.612), which raises the risk of testing lower supports.
Momentum:
Trend structure (moving averages):
Key levels:
Quant/Pattern forward read: Similar-candlestick analog suggests ~60% chance of -1.98% next day, -1.3% next week, -13.52% next month — not aligned with an “impatient buy-now” approach.
Intellectia Proprietary Trading Signals

scheduled 2026-02-02 pre-market, which can amplify moves and complicate an impatient entry.
Latest quarter provided: 2025/Q3
Growth read: Broad deceleration across revenue, earnings, and margin indicates weakening operating leverage—consistent with the negative FY2025 profitability headlines. This backdrop reduces the probability that dips are immediately bought for a fast upside move.
On 2026-01-29, Morgan Stanley downgraded PKX to Equal Weight from Overweight while raising the price target to KRW 380,000 from KRW 360,000. The message is mixed: lithium exposure could support sentiment if lithium prices rise, but Wall Street’s key concern is that the core steel earnings/margin recovery is slower, limiting near-term upside.
Wall Street pros: lithium optionality + strategic investment; potential interest if lithium prices strengthen. Wall Street cons: steel-cycle recovery lagging; limited scope for material upside in the near term.
Influential/political trading: No recent congress trading data available; hedge fund and insider activity shown as neutral with no significant recent trend.